Literature DB >> 16450377

Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors.

Christopher M Heaphy1, Marco Bisoffi, Colleen A Fordyce, Christina M Haaland, William C Hines, Nancy E Joste, Jeffrey K Griffith.   

Abstract

Cancer arises from an accumulation of mutations that promote the selection of cells with progressively malignant phenotypes. Previous studies have shown that genomic instability, a hallmark of cancer cells, is a driving force in this process. In the present study, two markers of genomic instability, telomere DNA content and allelic imbalance, were examined in two independent cohorts of mammary carcinomas. Altered telomeres and unbalanced allelic loci were present in both tumors and surrounding histologically normal tissues at distances at least 1 cm from the visible tumor margins. Although the extent of these genetic changes decreases as a function of the distance from the visible tumor margin, unbalanced loci are conserved between the surrounding tissues and the tumors, implying cellular clonal evolution. Our results are in agreement with the concepts of "field cancerization" and "cancer field effect," concepts that were previously introduced to describe areas within tissues consisting of histologically normal, yet genetically aberrant, cells that represent fertile grounds for tumorigenesis. The finding that genomic instability occurs in fields of histologically normal tissues surrounding the tumor is of clinical importance, as it has implications for the definition of appropriate tumor margins and the assessment of recurrence risk factors in the context of breast-sparing surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16450377     DOI: 10.1002/ijc.21815

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  40 in total

1.  Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence.

Authors:  Xin Zhou; Alan K Meeker; Kepher H Makambi; Ourania Kosti; Bhaskar V S Kallakury; Mary K Sidawy; Christopher A Loffredo; Yun-Ling Zheng
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

2.  Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk.

Authors:  Robert T Chatterton; Richard E Heinz; Angela J Fought; David Ivancic; Claire Shappell; Subhashini Allu; Susan Gapstur; Denise M Scholtens; Peter H Gann; Seema A Khan
Journal:  Horm Cancer       Date:  2016-02-22       Impact factor: 3.869

Review 3.  The Stem Cell Network model: clinical implications in cancer.

Authors:  Rubén Cabanillas; José L Llorente
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-20       Impact factor: 2.503

4.  DNA methylation: a marker for carcinogen exposure and cancer risk.

Authors:  Takeshi Nakajima; Shotaro Enomoto; Toshikazu Ushijima
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

5.  Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer.

Authors:  Timothy M Barrow; Ludovic Barault; Rachel E Ellsworth; Holly R Harris; Alexandra M Binder; Allyson L Valente; Craig D Shriver; Karin B Michels
Journal:  Int J Cancer       Date:  2015-01-21       Impact factor: 7.396

Review 6.  Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.

Authors:  Paul Lochhead; Andrew T Chan; Reiko Nishihara; Charles S Fuchs; Andrew H Beck; Edward Giovannucci; Shuji Ogino
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

7.  Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases.

Authors:  M Bartova; J Hlavaty; Y Tan; C Singer; K Pohlodek; J Luha; I Walter
Journal:  Clin Exp Metastasis       Date:  2017-06-17       Impact factor: 5.150

8.  Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling.

Authors:  Kristy A Warner; Marta Miyazawa; Mabel M R Cordeiro; William J Love; Matthew S Pinsky; Kathleen G Neiva; Aaron C Spalding; Jacques E Nör
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

9.  Allelotyping identification of genomic alterations in rectal chromosomally unstable tumors without preoperative treatment.

Authors:  Benoît Romain; Agnès Neuville; Nicolas Meyer; Cécile Brigand; Serge Rohr; Anne Schneider; Marie-Pierre Gaub; Dominique Guenot
Journal:  BMC Cancer       Date:  2010-10-18       Impact factor: 4.430

10.  Genomic instability demonstrates similarity between DCIS and invasive carcinomas.

Authors:  Christopher M Heaphy; Marco Bisoffi; Nancy E Joste; Kathy B Baumgartner; Richard N Baumgartner; Jeffrey K Griffith
Journal:  Breast Cancer Res Treat       Date:  2008-09-11       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.